-
-
-
-
-
A413926-100mgInformationAMG 337 AMG 337 is an oral, small molecule, ATP-competitive, highly selective inhibitor of the Met (c-Met) receptor with an IC50 of 1 nM.TargetsMET receptor (Cell-free assay): MET(H1094R) (Cell-free assay): MET(M1250T) (Cell-free assay):
-
A413926-25mgInformationAMG 337 AMG 337 is an oral, small molecule, ATP-competitive, highly selective inhibitor of the Met (c-Met) receptor with an IC50 of 1 nM.TargetsMET receptor (Cell-free assay): MET(H1094R) (Cell-free assay): MET(M1250T) (Cell-free assay):
-
A413926-50mgInformationAMG 337 AMG 337 is an oral, small molecule, ATP-competitive, highly selective inhibitor of the Met (c-Met) receptor with an IC50 of 1 nM.TargetsMET receptor (Cell-free assay): MET(H1094R) (Cell-free assay): MET(M1250T) (Cell-free assay):
-
A413926-5mgInformationAMG 337 AMG 337 is an oral, small molecule, ATP-competitive, highly selective inhibitor of the Met (c-Met) receptor with an IC50 of 1 nM.TargetsMET receptor (Cell-free assay): MET(H1094R) (Cell-free assay): MET(M1250T) (Cell-free assay):
-
A286753-100mgPotent dual CRTH2 and prostaglandin D2(PGD2) receptor antagonist.
-
A286753-10mgPotent dual CRTH2 and prostaglandin D2(PGD2) receptor antagonist.
-
A286753-25mgPotent dual CRTH2 and prostaglandin D2(PGD2) receptor antagonist.
-
A286753-50mgPotent dual CRTH2 and prostaglandin D2(PGD2) receptor antagonist.